#AirForce #Cancer #LegalHelpForVeterans #VADisability

For the full article: https://www.legalhelpforvetera....ns.com/2022/05/17/po

00:00 - Introduction
00:14 - Aviator Cancer Examination Study Act
00:51 - 2021 National Defense Authorization Act
01:11 - Eligibility for Service-Connected Disability Benefits
01:34 - Aviator Cancer Studies
02:36 - Pentagon data review
03:27 - Conclusion

Last month, a very important bill was introduced that aims to research a possible link between aviation veterans and increased cancer rates.

The bill was introduced by U.S. Representative August Pfleuger from Texas and is being called the Aviator Cancer Examination Study Act or "ACES Act." If passed, it would require VA to determine the rates of cancer diagnosis' in military air and ground crews and to identify the "chemicals, compounds, agents, or other phenomena" they were exposed to. Additionally, it would require VA to determine whether there is "a scientifically established causal link between such a chemical, compound, agent, or other phenomena and such cancer incidence or mortality risk."

This bill differs from legislation passed in the 2021 National Defense Authorization Act by requiring toxin identification regardless of whether an overall elevated cancer incidence is found. The goal is to ensure individual military aviation veterans with cancer will be able to have their health care covered more quickly.

While the ACES Act is focused on veterans obtaining VA health care, aviation veterans should be aware that they may be eligible for service-connected disability benefits which can be established on a direct basis. This means medical evidence establishes a veteran's cancer was as likely as not caused by an in-service toxic exposure - which is about a 50/50 chance.

If you are an aviation veteran or know one who was exposed to toxic chemicals, please call us for assistance at (800) 693-4800

This 16-minute video will help you understand the medical breakdown of Veterans with bladder cancer. Jennifer M. Taylor, MD, MPH, from Michael E. DeBakey VAMC and Baylor College of Medicine, Houston, TX, discusses the biological breakdown of bladder cancer and treatments, highlighting issues found in the Veteran population. Dr. Taylor also discusses clinical trials in Veterans.

For a transcript of this presentation, click here: http://bit.ly/29BaQYV

This is Part 1 of 4 of the Patient Insight Webinars in the Veterans & Bladder Cancer Series.

In this 9-minute video, Jennifer Dimick, LISW-S, OSW-C, from Louis Stokes Cleveland VAMC, Cleveland, OH, discusses the psychosocial issues affecting Veterans faced with a bladder cancer diagnosis and provides an explanation of VA resources available to the Veteran population.

For a transcript of this presentation, click here: http://bit.ly/29Bb56o

This is Part 2 of 4 of the Patient Insight Webinars in the Veterans & Bladder Cancer Series.

The Veteran Health Administration’s National Oncology Program Office (NOP) is leading the future of cancer care and standing shoulder to shoulder with Veterans diagnosed with cancer. Clinical trials are one of the ways that NOP does this. By participating, Veterans can not only receive some of the most cutting edge care, but help form how cancer is treated in the future.

Learn more at https://www.Cancer.VA.gov



#ClinicalTrials #CancerResearch #Cancer

Veteran Jackson Gerrard was diagnosed with Myelodysplastic Syndrome in February 2021. But thanks to VA's National TeleOncology service and the oncology staff at the Clarksburg VA Medical Center, Mr. Gerrard was able to get the cancer care he needed. More than 5,600 Veterans have benefited from this service. If you think this might be the right fit for you, visit https://cancer.va.gov/. #VADidThat #CancerCare #BeatCancer

In this 16-minute video, Tom Berger, Ph.D., Executive Director of the Veterans Health Council of the Vietnam Veterans of America, discusses in more detail the possible link between bladder cancer and Agent Blue in comparison to other rainbow herbicides, as well as the challenges associated with filing a claim based on a direct link to Agent Blue. Dr. Berger also gives a step-by-step procedure for filing a claim through the VA.

For a transcript of this presentation, click here: http://bit.ly/29ClTDB

This is Part 3 of 4 of the Patient Insight Webinars in the Veterans & Bladder Cancer Series.

In this 9-minute video, Jennifer Taylor, MD, Jennifer Dimick, LISW-S, OSW-C, and Tom Berger, Ph.D., answer questions posed by Veterans concerning various topics about bladder cancer and the VA system.

For a transcript of this presentation, click here: http://bit.ly/29pRExq

This is Part 4 of 4 of the Patient Insight Webinars in the Veterans & Bladder Cancer Series.